Windtree establishes a fund of 500 million USD to purchase BNB as treasury assets.

Biotechnology company Windtree Therapeutics (Nasdaq: WINT) has just announced the establishment of an equity capital limit of up to 500 million USD and signed a stock purchase agreement worth 20 million USD with Build and Build Corp. 99% of the total raised funds will be used to purchase BNB, serving the company's cryptocurrency treasury asset strategy.

This capital limit will not be utilized until shareholders approve the increase in the number of common shares allowed to be issued.

CEO Windtree stated that integrating new sources of capital is a necessary step to expand BNB holdings. The director of Build and Build Corp noted that the strategy of integrating BNB demonstrates a long-term vision in creating value for shareholders through digital assets.

Windtree, a company operating in the biotechnology sector, shifting strongly towards digital asset accumulation such as BNB, reflects an increasingly evident trend: more and more traditional businesses are turning to cryptocurrencies as part of their capital management and asset diversification strategies in the modern financial environment.